secwatch.observer — SEC 8-K summary
======================================

Issuer:     Varex Imaging Corp (VREX)
CIK:        0001681622
Form:       8-K
Filed at:   2024-05-02T23:59:59+00:00
Accession:  0001681622-24-000058
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Varex Q2 revenue $206M, down 10% YoY; lowers H2 outlook due to China softness
-----------------------------------------------------------------------------

- Revenue $206M, down 10% YoY; GAAP EPS $0.03, Non-GAAP EPS $0.16 (down from $0.26).
- Medical segment revenue $149M (-15% YoY); Industrial $57M (+6% YoY).
- Non-GAAP gross margin 33% flat YoY; operating cash flow $3M.
- Q3 guidance: revenue $200-220M, non-GAAP EPS $0.05-$0.25; management lowered H2 expectations.
- CEO cited continued softness in China as primary headwind for medical segment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681622/000168162224000058/0001681622-24-000058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681622/000168162224000058/vrex-20240502.htm
  HTML page:      https://secwatch.observer/filing/0001681622-24-000058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer